Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olivia Slater

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Organic & Biomolecular Chemistry|August 8, 2025
Elucidating structural and molecular requirements of somatostatin subtype-4 agonist bound complexes using quantum mechanics approachesOlivia Slater, Maria Kontoyianni
Expert Opinion on Drug Discovery|April 27, 2019
The compromise of virtual screening and its impact on drug discoveryOlivia Slater, Maria Kontoyianni
Molecules (Basel, Switzerland)|October 29, 2025
Factors Driving Amyloid Beta Fibril Recognition by Cell Surface Receptors: A Computational StudyOlivia Slater, Maria Kontoyianni
Current Topics in Medicinal Chemistry|February 27, 2020
Decoding Protein-protein Interactions: An OverviewOlivia Slater, Bethany Miller, Maria Kontoyianni
ACS Infectious Diseases|May 25, 2022
Development of a Simple and Effective Lipid-A Antagonist Based on Computational PredictionOlivia Slater, Kapur B Dhami, Ganesh Shrestha, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
5,5'-Methylenedisalicylic Acid Derivatives as Inhibitors of the Protein Phosphatase CppA in <i>Chlamydia trachomatis</i>Krishna Pandey, Olivia Slater, Gabrielle E Jeschke, et al.
RSC Medicinal Chemistry|December 23, 2024
3-Thio-3,4,5-trisubstituted-1,2,4-triazoles: high affinity somatostatin receptor-4 agonist synthesis and structure-activity relationshipsA Michael Crider, Audrey Hospital, Karin E Sandoval, et al.
RSC Medicinal Chemistry|August 30, 2021
Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatmentWilliam L Neumann, Karin E Sandoval, Shirin Mobayen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Organic & Biomolecular Chemistry|August 8, 2025
Elucidating structural and molecular requirements of somatostatin subtype-4 agonist bound complexes using quantum mechanics approachesOlivia Slater, Maria Kontoyianni
Expert Opinion on Drug Discovery|April 27, 2019
The compromise of virtual screening and its impact on drug discoveryOlivia Slater, Maria Kontoyianni
Molecules (Basel, Switzerland)|October 29, 2025
Factors Driving Amyloid Beta Fibril Recognition by Cell Surface Receptors: A Computational StudyOlivia Slater, Maria Kontoyianni
Current Topics in Medicinal Chemistry|February 27, 2020
Decoding Protein-protein Interactions: An OverviewOlivia Slater, Bethany Miller, Maria Kontoyianni
ACS Infectious Diseases|May 25, 2022
Development of a Simple and Effective Lipid-A Antagonist Based on Computational PredictionOlivia Slater, Kapur B Dhami, Ganesh Shrestha, et al.
ACS Medicinal Chemistry Letters|February 18, 2026
5,5'-Methylenedisalicylic Acid Derivatives as Inhibitors of the Protein Phosphatase CppA in <i>Chlamydia trachomatis</i>Krishna Pandey, Olivia Slater, Gabrielle E Jeschke, et al.
RSC Medicinal Chemistry|December 23, 2024
3-Thio-3,4,5-trisubstituted-1,2,4-triazoles: high affinity somatostatin receptor-4 agonist synthesis and structure-activity relationshipsA Michael Crider, Audrey Hospital, Karin E Sandoval, et al.
RSC Medicinal Chemistry|August 30, 2021
Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatmentWilliam L Neumann, Karin E Sandoval, Shirin Mobayen, et al.
Pageof 1